No Data
No Data
Open Source Securities: Blue Ocean of Collagen Medical Beauty Market Awaits Exploration, and High-end Consumer Group Leads the Trend.
In 2023, the penetration rate of recombined collagen protein medical beauty products is expected to be less than 20% among high-end consumers, but Open Source Securities believes that its differentiated benefits such as anti-aging around the eyes and improving facial fine lines have the potential to seize the budget of competing products.
Zhejiang Feida Environmental Technology Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Zhejiang Feida Environmental Technology Co., Ltd.
Zhejiang Feida Enviromental Science & Technology (600526.SH) released its semi-annual performance with a net income of 111 million yuan, a year-on-year growth of 33.68%.
Zhejiang Feida Environmental Science & Technology (600526.SH) disclosed its semi-annual report for 2024, during the reporting period, the company achieved revenue of 14.6...
Zhejiang Feida Environmental Science & Technology (600526.SH): No involvement in textile-related business.
Zhejiang Feida Environmental Science & Technology (600526.SH) stated on the investor interaction platform on July 31st that the company's main business is the production and sales of atmospheric pollution control equipment, as well as domestic water affairs related to eco-friendly concept, and has not been involved in textile-related business.
Zhejiang Feida Environmental Science & Technology (600526.SH) granted 2.55 million restricted stocks to 48 incentive objects.
Zhejiang Feida Environmental Science & Technology (600526.SH) has released an announcement. The board of directors believes that the company's restricted stock incentive plan for 2023...
No Data
No Data